Barclays Upgrades Thoratec (THOR) to Overweight, Price Target $39
Tweet Send to a Friend
Barclays upgraded Thoratec (NASDAQ: THOR) to an Overweight rating from its previous ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


